Arcturus Therapeutics Holdings Inc. Share Price
NASDAQ: ARCT | Small CapArcturus Therapeutics Holdings Inc. Stock Performance
Arcturus Therapeutics Holdings Inc. Share Price Today
As of 29 October 2026, Arcturus Therapeutics Holdings Inc.'s share price is $12.41. The stock opened at $12.04, compared to its previous close of $12.06. During today's trading session, Arcturus Therapeutics Holdings Inc.'s share price traded between $12.04 and $12.24, with an average price of $12.14. Over the past 52 weeks, the stock has recorded a high of $17.90 and a low of $5.50. In terms of performance, Arcturus Therapeutics Holdings Inc.'s share price has risen by 43.97% over the last six months and is up 24.22% on a year-on-year basis.
Arcturus Therapeutics Holdings Inc. Share Price Chart
Arcturus Therapeutics Holdings Inc. Quarterly Profit & Loss
All figures in USD
Arcturus Therapeutics Holdings Inc. Annual Profit & Loss
All figures in USD
About Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
Arcturus Therapeutics Holdings Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $13.47 | $12.24 | -10.85% |
Sep 2026 | $15.13 | $13.73 | -15.14% |
Aug 2026 | $5.86 | $16.18 | +181.15% |
Jul 2026 | $6.83 | $5.75 | -14.23% |
Jun 2026 | $7.71 | $6.71 | -15.49% |
May 2026 | $8.54 | $7.94 | -7.89% |
Apr 2026 | $7.99 | $8.62 | +11.51% |
Mar 2026 | $8.07 | $7.73 | -6.30% |
Feb 2026 | $7.37 | $8.25 | +10.15% |
Jan 2026 | $6.19 | $7.49 | +22.59% |
Dec 2025 | $6.47 | $6.11 | -9.75% |
Nov 2025 | $10.04 | $6.77 | -32.23% |